In regard to DFS, only the AJCC stage retained its statistical significance after adjustments for other prognostic factors including CD151 expression, subtypes, and adjuvant chemotherapy, suggesting that AJCC stage is a strong predictor of recurrence of breast cancer superior to other prognostic factors in this study. The gene discussed is CD151; the disease is breast carcinoma.